Diovan HCT is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Valsartan; Hydrochlorothiazide.
| Product ID | 0078-0315_0fa1a408-909e-4098-96ac-2bef1bd97298 |
| NDC | 0078-0315 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Diovan HCT |
| Generic Name | Valsartan And Hydrochlorothiazide |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1998-03-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020818 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | VALSARTAN; HYDROCHLOROTHIAZIDE |
| Active Ingredient Strength | 160 mg/1; mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1998-03-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-03-06 |
| Marketing End Date | 2017-05-31 |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-03-06 |
| Marketing End Date | 2015-08-10 |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2011-01-25 |
| Marketing End Date | 2015-08-10 |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-04-06 |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-03-06 |
| Marketing Category | NDA |
| Application Number | NDA020818 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-08-29 |
| Marketing End Date | 2015-08-10 |
| Ingredient | Strength |
|---|---|
| VALSARTAN | 160 mg/1 |
| SPL SET ID: | d76a0419-05ee-437e-884c-65807aea9569 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide |
| 68258-6056 | Diovan HCT | Diovan HCT |
| 68258-6053 | Diovan HCT | Diovan HCT |
| 68258-6972 | Diovan HCT | Diovan HCT |
| 68258-6973 | Diovan HCT | Diovan HCT |
| 55289-820 | Diovan HCT | Diovan HCT |
| 55289-838 | Diovan HCT | Diovan HCT |
| 0378-6321 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
| 0378-6322 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
| 0378-6323 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DIOVAN HCT 75189097 2182834 Live/Registered |
NOVARTIS CORPORATION 1996-10-28 |